Sign in
Taking people in NetherlandsPhase 1

Testing a PET scan imaging agent for lung cancer in adults

Tests a 68Ga-FAPI PET scan to image non-small cell lung cancer in adults.

Key facts

Who runs it
Meander Medisch Centrum
Where
Amersfoort, NetherlandsSee the site
Registry title
Performance and prognostic value of 68Ga-FAPI PET/CT in non-small cell lung cancer (NSCLC)
Status
Recruiting
Phase
Phase 1
People taking part
20 people, planned
Started
7 Nov 2023
Planned end
31 Oct 2024
Type of study
Interventional
Record updated
24 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with non-small cell lung cancer. It studies how well a 68Ga-FAPI PET/CT scan works and what it can tell about the course of the disease.

Age
18 years or older
Sex
Women and men can join.
Disease stage
Non-small cell lung cancer. The record does not give a stage.

Where in Netherlands

  • Meander Medical CenterAmersfoort, NetherlandsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
Testing a PET scan imaging agent for lung cancer in adultsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
24 June 2026